Intra-abdominal adipose tissue is independently associated with sex-hormone binding globulin in premenopausal women

Obesity

Volumn 20, Issue 5, 2012, Pages 1012-1015

  Azrad, Maria ^a   Gower, Barbara A ^a   Hunter, Gary R ^a   Nagy, Tim R ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SEX HORMONE BINDING GLOBULIN;

ADULT; AGE; ARTICLE; BODY COMPOSITION; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; OBESITY; PREMENOPAUSE; PROTEIN BLOOD LEVEL; TIME; WEIGHT REDUCTION;

ABSORPTIOMETRY, PHOTON; ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; LONGITUDINAL STUDIES; METABOLIC SYNDROME X; OBESITY; PREMENOPAUSE; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN;

EID: 84860273575     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.375     Document Type: Article

References (25)

1. Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH. Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 1983;57:304-310.
2. Kaaks R, Berrino F, Key T et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005;97:755-765.
3. Potischman N, Hoover RN, Brinton LA et al. Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 1996;88:1127-1135.
4. Sutton-Tyrrell K, Wildman RP, Matthews KA et al.; SWAN Investigators. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation(SWAN). Circulation 2005;111:1242-1249.
5. Pugeat M, Nader N, Hogeveen K et al. Sex hormone-binding globulin gene expression in the liver: Drugs and the metabolic syndrome. Mol Cell Endocrinol 2010;316:53-59.
6. Haffner SM, Valdez RA, Morales PA, Hazuda HP, Stern MP. Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men. J Clin Endocrinol Metab 1993;77:56-60.
7. Morisset AS, Blouin K, Tchernof A. Impact of diet and adiposity on circulating levels of sex hormone-binding globulin and androgens. Nutr Rev 2008;66:506-516.
8. Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormonebinding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab 1988;67:460-464.
9. Selva DM, Hogeveen KN, Innis SM, Hammond GL. Monosaccharideinduced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. J Clin Invest 2007;117:3979-3987.
10. Selva DM, Hammond GL. Peroxisome-proliferator receptor gamma represses hepatic sex hormone-binding globulin expression. Endocrinology 2009;150:2183-2189.
11. Selva DM, Hammond GL. Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepatocyte nuclear factor-4alpha. J Mol Endocrinol 2009;43:19-27.
12. Nayeem F, Nagamani M, Anderson KE et al. Dietary beta-tocopherol and linoleic acid, serum insulin, and waist circumference predict circulating sex hormone-binding globulin in premenopausal women. J Nutr 2009;139:1135-1142.
13. Maggio M, Lauretani F, Basaria S et al. Sex hormone binding globulin levels across the adult lifespan in women-the role of body mass index and fasting insulin. J Endocrinol Invest 2008;31:597-601.
14. Pasquali R, Vicennati V, Bertazzo D et al. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group. Metab Clin Exp 1997;46:5-9.
15. Yeung EH, Zhang C, Hediger ML, Wactawski-Wende J, Schisterman EF. Racial differences in the association between sex hormone-binding globulin and adiposity in premenopausal women: The BioCycle study. Diabetes Care 2010;33:2274-2276.
16. Jenson MD. Role of body fat distribution and the metabolic complications of obesity. J Clin Endocrinol Metab 2008;93:S57-S63.
17. Tchernof A, Toth MJ, Poehlman ET. Sex hormone-binding globulin levels in middle-Aged premenopausal women. Associations with visceral obesity and metabolic profile. Diabetes Care 1999;22:1875-1881.
18. Hunter GR, Brock DW, Byrne NM et al. Exercise training prevents regain of visceral fat for 1 year following weight loss. Obesity (Silver Spring)2010;18:690-695.
19. Singer JD, Willett JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurence. Oxford University Press: New York, 2003, pp 3-15.
20. Jensen MD. Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity (Silver Spring) 2006;14 Suppl 1:20S-24S.
21. Jänne M, Hammond GL. Hepatocyte nuclear factor-4 controls transcription from a TATA-less human sex hormone-binding globulin gene promoter. J Biol Chem 1998;273:34105-34114.
22. Hertz R, Magenheim J, Berman I, Bar-Tana J. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4alpha. Nature 1998;392:512-516.
23. Wisely GB, Miller AB, Davis RG et al. Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure 2002;10:1225-1234.
24. Peter A, Kantartzis K, Machann J et al. Relationships of circulating sex hormone-binding globulin with metabolic traits in humans. Diabetes 2010;59:3167-3173.
25. Fabbrini E, Magkos F, Mohammed BS et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 2009;106:15430-15435.